MASTER AGREEMENT by and between MPI RESEARCH, INC. (hereinafter referred to as MPI) Mattawan, Michigan and PHAGE BIOTECHNOLOGY CORPORATION (hereinafter referred to as the SPONSOR) Tustin, CaliforniaMaster Agreement • November 26th, 2004 • CardioVascular BioTherapeutics, Inc. • Pharmaceutical preparations • Michigan
Notice: This document contains Company Confidential and/or Proprietary Information belonging to MPI and the Sponsor. None of the information may be copied, transmitted or communicated in whole or in part to any third party without the written consent of the parties.
SERVICE AGREEMENTService Agreement • November 26th, 2004 • CardioVascular BioTherapeutics, Inc. • Pharmaceutical preparations • California
This agreement entered into by and between Cardio Vascular Genetic Engineering Inc., a Delaware corporation (“Cardio” or “the Company”) and BS Biology Sciences Limited, a Cyprus” Corporation (“Service Provider).
AGREEMENT on TECHNOLOGY & BUSINESS RIGHT TRANSFER between Cardio Vascular Genetic Engineering Inc. (a Delaware Corporation) and Korea Biotechnology Development Co., Ltd. (a Korean Corporation) Dated December 15, 2000Technology Transfer Agreement • November 26th, 2004 • CardioVascular BioTherapeutics, Inc. • Pharmaceutical preparations
This agreement confirms the rights and duties of the relating two parties regarding to a technology and business right transfer for the manufacturing and the exclusive marketing territory of the Cardio Vascular Genetic Engineering Inc. and it’s biotechnology products.
CARDIOVASCULAR BIOTHERAPEUTICS, INC. 2,000,000 Shares Common Stock UNDERWRITING AGREEMENT dated , 2004 First Dunbar Securities CorporationUnderwriting Agreement • November 26th, 2004 • CardioVascular BioTherapeutics, Inc. • Pharmaceutical preparations • Delaware
